Atea Pharmaceuticals, Inc. (AVIR) has 20 known insider and institutional holders on record. The largest holder is LESCHLY JAN with 30,793,670 shares. Other notable holders include PATTI JOSEPH M and COLONNESE MARK P.
Over the last 12 months, insiders have made 16 transactions in AVIR stock — 2 buys (valued at $610K) and 0 sells (valued at RSU Award). Insider buying has outpaced selling during this period, which may signal confidence in the company's prospects.
AVIR Insider Ownership
Top Holder
LESCHLY JAN
30,793,670 shares
Buys (12 mo)
2
$610K value
Sells (12 mo)
0
$0.00 value
12-Month Transaction Activity
Top Insider Holders
| # |
Name |
Role |
Shares Owned |
Last Filed |
Relative Size |
| 1 |
Leschly Jan |
10 Percent Owner |
30,793,670 |
2018-02-15 |
|
| 2 |
Patti Joseph M |
CEO |
2,113,304 |
2017-04-05 |
|
| 3 |
Colonnese Mark P |
Chief Financial Officer |
775,000 |
2017-04-05 |
|
| 4 |
Berger Franklin M |
Director |
466,897 |
2025-01-17 |
|
| 5 |
Berman Howard |
Director |
164,800 |
2025-06-24 |
|
| 6 |
Dougherty Michael R |
Director |
105,000 |
2017-05-22 |
|
| 7 |
Sommadossi Jean-pierre |
President, CEO, and Chairman |
99,518 |
2025-02-04 |
|
| 8 |
Hack Andrew A. F. |
Director |
80,000 |
2020-10-30 |
|
| 9 |
Cheng Isaac |
Director |
80,000 |
2020-10-30 |
|
| 10 |
Anido Armando |
Director |
75,000 |
2017-05-22 |
|
| 11 |
Dunne Michael W. |
Director |
75,000 |
2017-05-22 |
|
| 12 |
Polsky Bruce |
Director |
65,606 |
2024-06-21 |
|
| 13 |
Murphy Polly A. |
Director |
29,600 |
2024-06-21 |
|
| 14 |
Adams Jerome M. |
Director |
29,600 |
2024-06-21 |
|
| 15 |
Duncan Barbara Gayle |
Director |
29,600 |
2024-06-21 |
|
| 16 |
Lucidi Bruno |
Director |
29,600 |
2024-06-21 |
|
| 17 |
Hammond Janet Mj |
Chief Development Officer |
11,250 |
2025-02-04 |
|
| 18 |
Corcoran Andrea |
See Remarks |
10,500 |
2025-02-04 |
|
| 19 |
Kirsch Arthur S |
Director |
10,000 |
2025-02-24 |
|
| 20 |
Horga Maria Arantxa |
Chief Medical Officer |
9,750 |
2025-02-04 |
|
Recent Transactions (last 12 months)
| Date |
Name |
Role |
Type |
Shares |
Price |
Value |
| 2026-03-11 |
Corcoran Andrea |
See Remarks |
Option Exercise |
60,000 |
$1.24 |
$74.4K |
| 2026-01-31 |
Hammond Janet Mj |
Chief Development Officer |
Option Exercise (Sell) |
11,250 |
- |
- |
| 2026-01-31 |
Vavricka John |
Chief Commercial Officer |
Option Exercise (Sell) |
8,750 |
- |
- |
| 2026-01-31 |
Horga Maria Arantxa |
Chief Medical Officer |
Option Exercise (Sell) |
9,750 |
- |
- |
| 2026-01-31 |
Foster Wayne |
EVP, Chief Accounting Officer |
Option Exercise (Sell) |
8,000 |
- |
- |
| 2026-01-31 |
Corcoran Andrea |
See Remarks |
Option Exercise (Sell) |
10,500 |
- |
- |
| 2026-02-03 |
Sommadossi Jean-pierre |
President, CEO, and Chairman |
Option Exercise (Sell) |
300,000 |
$1.24 |
$372K |
| 2026-01-31 |
Sommadossi Jean-pierre |
President, CEO, and Chairman |
Option Exercise (Sell) |
99,517 |
- |
- |
| 2025-06-20 |
Berman Howard |
Director |
RSU Award |
164,800 |
$3.25 |
$535.6K |
| 2025-06-20 |
Berman Howard |
Officer |
Unknown |
- |
- |
- |
| 2025-06-20 |
Adams Jerome M. |
Director |
Option Exercise (Sell) |
29,600 |
- |
- |
| 2025-06-20 |
Lucidi Bruno |
Director |
Option Exercise (Sell) |
29,600 |
- |
- |
| 2025-06-20 |
Murphy Polly A. |
Director |
Option Exercise (Sell) |
29,600 |
- |
- |
| 2025-06-20 |
Polsky Bruce |
Director |
Option Exercise (Sell) |
29,600 |
- |
- |
| 2025-06-20 |
Duncan Barbara Gayle |
Director |
Option Exercise (Sell) |
29,600 |
- |
- |
| 2025-06-20 |
Berger Franklin M |
Director |
Option Exercise (Sell) |
29,600 |
- |
- |
